Elicio Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ELTX Nasdaq 2836 elicio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Elicio Therapeutics, Inc.

Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026 - Sep 24th, 2026 6:00 am
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference - Aug 31st, 2026 6:00 am
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference - Aug 24th, 2026 6:00 am
Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - Aug 13th, 2026 2:01 pm
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering - Jul 6th, 2026 2:05 pm
Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment - Jul 2nd, 2026 5:22 am
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering - Jul 1st, 2026 10:25 pm
Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes - Jun 29th, 2026 6:00 am
Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer - Jun 17th, 2026 6:00 am
This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation - Jun 16th, 2026 12:00 pm
Stocks Settle Sharply Higher as US-Iran Peace Deal Spurs Optimism - Jun 15th, 2026 2:36 pm
Sector Update: Healthcare Stocks Softer Late Afternoon - Jun 15th, 2026 1:46 pm
ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints - Jun 15th, 2026 12:50 pm
Top Midday Decliners - Jun 15th, 2026 12:01 pm
Stocks Rally as US-Iran Peace Deal Sinks Oil and Bond Yields - Jun 15th, 2026 9:19 am
Stocks Soar on US-Iran Peace Agreement - Jun 15th, 2026 8:15 am
Elicio Therapeutics Shares Plunge After Pancreatic Cancer Study Misses Main Goal (ELTX) - Jun 15th, 2026 7:45 am
Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer - Jun 15th, 2026 5:00 am
Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology - Jun 1st, 2026 6:00 am
Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates - May 11th, 2026 2:05 pm